#6100
Aspergillus
fumigatus IgG ELISA
ELISA kit for the diagnosis of human aspergillosis
Lot 2315A (Expiry date: 02.12.2024)
Production date : 03.04.2023
Results of quality control 1 (after
production), date: 06.04.2023
No serum blank (average) : 0.114
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.001 |
-0.003 |
0.003 |
0.002 |
0.000 |
0 |
Negative control serum
(N° 6100-06) |
0.050 |
0.047 |
0.066 |
0.064 |
0.057 |
3 |
Weak positive serum
(N° 6100-07) |
0.455 |
0.458 |
0.444 |
0.467 |
0.456 |
22 |
Positive control
serum
(N° 6100-08) |
2.058 |
2.168 |
1.994 |
2.103 |
2.081 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 6100-08 |
> 1.200 |
2.081 |
Yes |
Absorbance of weak positive serum 6100-07, as % of positive serum
|
> 11 % |
22 % |
Yes |
Absorbance of negative serum 6100-06, as % of positive serum |
< 8 % |
3 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.114 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|